Abbott Laboratories
No price chart data available for 1D timeframe.
Rating
Why Price Moved
Shares are trading higher after Abbott reported fa...
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of h...
Latest News
16 hours ago · zacks.com
Here's How Abbott's EP Business Is Shaping Up for the Rest of 2026ABT's EP business gains momentum as Volt adoption accelerates and new device launches expand its portfolio despite LAA market weakness.
17 hours ago · gurufocus.com
Is ABT Overvalued? DCF Says Worth $76On November 16, 2026, we delve into the DCF analysis for Abbott Laboratories (ABT), a company that has seen a challenging year with its stock price reflecting a
3 days ago · zacks.com
Should You Buy, Hold or Sell Abbott Stock Post-Q3 Earnings?ABT's strong Q3 results, broad-based segment growth and Nutrition spin-off plans support its outlook, despite softer 2026 sales guidance.
5 days ago · zacks.com
Is Trending Stock Abbott Laboratories (ABT) a Buy Now?Abbott (ABT) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
5 days ago · zacks.com
Can UltiSynq Lead Boost Abbott's Cardiac Rhythm Management Business?ABT's UltiSynq lead combines conduction system pacing and defibrillation, with strong clinical trial results supporting its potential to expand the company's cardiac rhythm management portfolio.
10 days ago · 247wallst.com
3 Medical Device Stocks That Keep Raising Dividends. One Just Hit 55 YearsHospitals reorder syringes, sensors, and implants whether the economy booms or stalls, and three device makers turn that habit into payouts that grow every year.
13 days ago · marketwatch.com
These 12 stocks are good bets to beat the 10-year Treasury over the next decadeInvestment newsletters' favorite Dividend Aristocrat stocks
15 days ago · benzinga.com
Abbott Touts Favorable Outcomes In Cardiovascular Device TrialsAbbott Laboratories (NYSE:ABT) reported positive clinical trial results for two investigational cardiovascular devices at the Transcatheter Cardiovascular Therapeutics conference in San Diego, demonstrating high procedural success and low complication rates in patients with irregular heart rhythms and severely calcified coronary arteries.
15 days ago · prnewswire.com
Late-breaking one-year data show Abbott's next-generation Amulet 360™ device continues to demonstrate high rates of left atrial appendage closure and low incidence of strokeLate-breaking one-year VERITAS study results were presented at the Transcatheter Cardiovascular Therapeutics conference and simultaneously published in JACC: Cardiovascular Interventions; data show the device achieved high closure rates of the left atrial appendage (LAA) and a low incidence of stroke Abbott's Amulet 360™ LAA Occluder is a next-generation device designed to reduce the risk of stroke and other serious blood clot-related complications in people with atrial fibrillation not caused by a heart valve issue ABBOTT PARK, Ill., Nov. 2, 2026 /PRNewswire/ -- Abbott (NYSE: ABT), the global healthcare leader, announced today one-year results for its investigational Amulet 360™ Left Atrial Appendage (LAA) Occluder from the VERITAS study, which show meaningful closure rates of the left atrial appendage and a low incidence of stroke in people with atrial fibrillation (AFib) not caused by a heart valve issue.
15 days ago · gurufocus.com
Abbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce™ Coronary Intravascular Lithotripsy SystemAbbott's TECTONIC clinical trial demonstrates strong 30-day outcomes and high procedural success for its investigational SonicForce⢠Coronary Intravascular Li
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove ABT